Compounds and compositions for treating conditions associated with nlrp activity
US-2024391884-A1 · Nov 28, 2024 · US
This page is not indexed by search engines while we improve data quality.
Glick Gary patents
Glick Gary is listed as an inventor on 19 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Glick Gary |
| Total patents | 19 |
| First publication | Dec 21, 2021 |
| Latest publication | Nov 28, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Compounds and compositions for treating conditions associated with NLRP activity
US-12084424-B2 · Sep 10, 2024 · US
Compounds and compositions for treating conditions associated with nlrp activity
US-2023416211-A1 · Dec 28, 2023 · US
Compounds and compositions for treating conditions associated with NLRP activity
US-11760735-B2 · Sep 19, 2023 · US
Compounds and compositions for treating conditions associated with NLRP activity
US-11724992-B2 · Aug 15, 2023 · US
Compounds and compositions for treating conditions associated with nlrp activity
US-2023099258-A1 · Mar 30, 2023 · US
Compounds and compositions for treating conditions associated with nlrp activity
US-2023079631-A1 · Mar 16, 2023 · US
Compounds and compositions for treating conditions associated with NLRP activity
US-11597706-B2 · Mar 7, 2023 · US
Compounds and compositions for treating conditions associated with nlrp activity
US-2023062815-A1 · Mar 2, 2023 · US
The compounds and compositions for treating conditions associated with nlrp activity
US-2023059136-A1 · Feb 23, 2023 · US
Recent patents
Latest publications not already listed above.
Compounds and compositions for treating conditions associated with nlrp activity
US-2023051589-A1 · Feb 16, 2023 · US
Compounds and compositions for treating conditions associated with nlrp activity
US-2023031406-A1 · Feb 2, 2023 · US
Methods of treating or selecting a treatment for a subject resistant to tnf inhibitor using a nlrp3 antagonist
US-2022339169-A1 · Oct 27, 2022 · US
Compounds and compositions for treating conditions associated with NLRP activity
US-11447460-B2 · Sep 20, 2022 · US
Nlrp modulators
US-2022267276-A1 · Aug 25, 2022 · US
Compounds and compositions for treating conditions associated with NLRP activity
US-11370763-B2 · Jun 28, 2022 · US
Compounds and compositions for treating conditions associated with NLRP activity
US-11339136-B2 · May 24, 2022 · US
Nlrp modulators
US-2021395241-A1 · Dec 23, 2021 · US
Compounds and compositions for treating conditions associated with NLRP activity
US-11203579-B2 · Dec 21, 2021 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Novartis Ag | 19 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07D417/12 | 17 |
| C07D277/36 | 17 |
| C07D333/34 | 16 |
| A61P35/00 | 16 |
| A61P1/00 | 16 |